HR Execs on the Move

Dracen Pharmaceuticals

www.dracenpharma.com

 
Dracen is a privately funded biotech company developing drugs in the area in of immuno metabolism.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.dracenpharma.com
  • 1812 Ashland and Avenue 1st Floor, Suite 100
    Baltimore, MD USA 21205
  • Phone: 917.398.3710

Executives

Name Title Contact Details
Tom Estok
President ,Chief Executive Officer, Director Profile

Similar Companies

Dripping Springs Pharmacy

Dripping Springs Pharmacy is a Dripping Springs, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Pharmacosmos

Pharmacosmos A/S is specialized in iron therapy. We develop, manufacture and market medicines for treatment of iron deficiency anaemia in humans and animals.

Elevar Therapeutics

Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. Elevar`s lead proprietary drug candidates include rivoceranib (apatinib) and Apealea® (paclitaxel micellar). Rivoceranib is the first small-molecule tyrosine kinase inhibitor (TKI) to be approved in gastric cancer (China, Dec 2014). It has been granted Orphan Drug designation in the U.S., Europe and South Korea and has been clinically tested in over 1,000 patients worldwide in numerous cancer indications. Apealea® (paclitaxel micellar) is a non-Cremophor EL based formulation of paclitaxel that received marketing authorization by the European Commission in November 2018, making it Europe`s first non-Cremophor EL formulation of paclitaxel approved for use in ovarian cancer. Elevar Therapeutics has offices in Utah, California and South Korea.

Horizon Behavioral Health

Behavioral health, Recovery, drug, rehabilitation, mental illness, depression, Appomattox, Appomattox County, Virginia, Central Virginia, alcoholism, Alcohol